
Pfizer's Covid Drug Paxlovid May Reduce the Risk of Developing Long Covid, Study Says
People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
-
Biden Signs Legislation to Declassify Certain Intelligence on Covid Pandemic Origins
Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.
-
New COVID Origins Data Suggest Pandemic Linked to Raccoon Dogs at Wuhan Market
Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, suggesting the pandemic may have originated f... -
Study Calls COVID's Mental Health Impact ‘Minimal.' The Responses Perfectly Capture 2020
‘It’s a way to speak back to the idea that all harm is measurable,’ according to a psychologist.
-
FDA Staff Report Says Data Shows Pfizer's Covid Treatment Paxlovid Is Effective in High-Risk Adults
FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.